Item Type | Name |
Concept
|
HLA-DP Antigens
|
Concept
|
HLA-DR Antigens
|
Concept
|
HLA-DQ Antigens
|
Concept
|
HLA Antigens
|
Concept
|
HLA-A2 Antigen
|
Concept
|
HLA-A Antigens
|
Concept
|
HLA-C Antigens
|
Concept
|
HLA-DP alpha-Chains
|
Concept
|
HLA-DRB1 Chains
|
Concept
|
HLA-DQ beta-Chains
|
Concept
|
HLA-B52 Antigen
|
Concept
|
HLA-DQ alpha-Chains
|
Concept
|
HLA-B Antigens
|
Concept
|
HLA-DR alpha-Chains
|
Concept
|
HLA-DP beta-Chains
|
Concept
|
HLA-A24 Antigen
|
Academic Article
|
Ring finger protein 43 as a new target for cancer immunotherapy.
|
Academic Article
|
Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
|
Academic Article
|
Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis.
|
Academic Article
|
HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.
|
Academic Article
|
HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis.
|
Academic Article
|
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.
|
Academic Article
|
New pharmacogenetic test for detecting an HLA-A*31: 01 allele using the InvaderPlus assay.
|
Academic Article
|
New sequence variants in HLA class II/III region associated with susceptibility to knee osteoarthritis identified by genome-wide association study.
|
Academic Article
|
Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen.
|
Academic Article
|
Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations.
|
Academic Article
|
Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
|
Academic Article
|
Development of new HLA-B*3505 genotyping method using Invader assay.
|
Academic Article
|
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.
|
Academic Article
|
HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
|
Academic Article
|
A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.
|
Academic Article
|
Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy.
|
Academic Article
|
A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.
|
Academic Article
|
A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region.
|
Academic Article
|
Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences.
|
Academic Article
|
An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes.
|
Academic Article
|
Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer.
|
Academic Article
|
[Phase I study of combination therapy with peptide vaccine and anti-cancer drug for colorectal cancer].
|
Academic Article
|
A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.
|
Academic Article
|
Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2).
|
Academic Article
|
HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study.
|
Academic Article
|
HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese.
|
Academic Article
|
Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray.
|
Academic Article
|
Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study.
|
Academic Article
|
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
|
Academic Article
|
A phase ?I study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).
|
Academic Article
|
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.
|
Academic Article
|
Identification of CDCA1-derived long peptides bearing both CD4+ and CD8+ T-cell epitopes: CDCA1-specific CD4+ T-cell immunity in cancer patients.
|
Academic Article
|
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer.
|
Academic Article
|
Identification of HLA-A24-restricted novel T Cell epitope peptides derived from P-cadherin and kinesin family member 20A.
|
Academic Article
|
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors.
|
Academic Article
|
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.
|
Academic Article
|
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy.
|
Academic Article
|
Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma.
|
Academic Article
|
Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.
|
Academic Article
|
Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors.
|
Academic Article
|
Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.
|
Academic Article
|
Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.
|
Academic Article
|
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer.
|
Academic Article
|
Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer.
|
Academic Article
|
Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer.
|
Academic Article
|
SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.
|
Academic Article
|
Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides.
|